Skip to content

EXplaining PLasticity after stroke

EXplaining PLasticity after stroke - EXPLORE-stroke:

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39598
Enrollment
100
Registered
2012-03-07
Start date
2012-08-15
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovasculair Accident CVA Stroke

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: regarding the primary objective: 1) an upper limb deficit, i.e. a NIHSS score of 1-4 in the second week post stroke; 2) a first-ever ischemic lesion in the territory of the MCA, verified by CT and/or MRI scan; 3) age between 40 and 75 years; 3) written or oral informed consent; 4) be able to sit for 30 seconds without support. Regarding the secondary objective: patients > 1 year post stroke with a motor deficit of the upper extremity NHSS *1; healthy volunteers within expected age range of stroke survivors, i.e. 40-75 years.

Exclusion criteria

Exclusion criteria: 1) a pacemaker or other metallic implants; 2) upper extremity orthopaedic limitations; 3) not being able to communicate i.e.

Design outcomes

Primary

MeasureTime frame
primary: cortico- muscular coherence, i.e. the concordance between brain and muscle activity at different brain areas, expressed as a fraction

Secondary

MeasureTime frame
Secondary: clinical outcome as measured by the Action Research Arm Test (ARAT), Motricity Index (MI) of arm and leg, Fugl-Meyer for the arm (FM-arm), Erasmus modification of the Nottingham Sensory Assessment (EmNSA), Letter Cancellation Task (LCT), Nine Hole Peg test (NHPT), a structured participant interview of real arm use using the Motor Activity Log (MAL), Stroke Impact Scale (SIS version 3.0) and Nottingham Extended ADL (NEADL).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)